Search for: "KING PHARMACEUTICALS, INC."
Results 161 - 180
of 212
Sort by Relevance
|
Sort by Date
7 Sep 2009, 9:34 pm
King Pharmaceuticals Inc. et al. v. [read post]
28 Aug 2009, 8:11 am
(patent infringement) 8/28: King Pharmaceuticals and Meridian Technologies Inc. v. [read post]
19 Aug 2009, 6:25 am
The Perry settlement arose from the failed attempt by Mylan Laboratories, Inc. to acquire King Pharmaceuticals, Inc. in 2004. [read post]
17 Aug 2009, 10:44 am
Tile, Inc. [read post]
16 Aug 2009, 11:23 am
The best example of the downside of optionality was the sale of United Rentals Inc. where the buyer, Cerberus, unabashedly chose to pay the break fee rather than close, despite the absence of any material problem in the URI business. [read post]
13 Aug 2009, 4:07 am
Janssen Pharmaceutical, Inc., ___ A.2d ___, 2009 WL 1857395 (Pa. [read post]
25 May 2009, 2:59 pm
', January 2009Jun He Law Offices- 'The Supreme Court Issues Opinions on Due Implementation of NationalIntellectual Property Strategy', April 30, 2009, [www.junhe.com]Kangxin- 'SARFT offers 9 mln yuan to support original cartoon', February 11, 2009. [124.207.176.104:8080]- 'China to build 100 IP assistance centers', February 10, 2009. [124.207.176.104:8080]King & Wood- IP Bulletin, February 2009, Shi Yusheng, 'Microsoft's Windows Genuine… [read post]
24 Mar 2009, 11:54 am
HNTB Georgia, Inc. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
23 Feb 2009, 9:59 pm
By Suresh Pillai --King Pharmaceuticals' Patents on SKELAXIN ® Invalidated By District Court In the case of King Pharmaceuticals, Inc. v. [read post]
11 Feb 2009, 1:55 pm
The agency sent letters to 16 manufacturers of 24 products including Purdue Pharma LP, the maker of OxyContin, which is available in an extended-release form; a unit of Johnson & Johnson that makes a fentanyl patch; and King Pharmaceuticals Inc., the maker of an extended-release form of morphine. [read post]
30 Jan 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: AIPLA urges Federal Circuit not to proscribe patents for biomedical diagnostic tools: Prometheus v Mayo (Inventive Step) (Hal Wegner) (Patently-O) (Holman's Biotech IP Blog) Lovenox (Enoxaparin) – US: Aventis files for certiorari: challenging Federal Circuit’s low standard for intent to deceive in inequitable… [read post]
23 Jan 2009, 7:49 am
King Pharmaceuticals, Inc et al v. [read post]
21 Jan 2009, 11:27 pm
"King Pharmaceuticals, Inc. v. [read post]
31 Dec 2008, 10:14 am
It took a few months, but--with help from lawyers at Dewey & LeBoeuf and Simpson Thacher--King Pharmaceuticals has completed its $1.6 billion acquisition of Alpharma, Inc. [read post]
9 Dec 2008, 11:51 pm
After leaving the Fed, he was general counsel at American International Group, Inc. [read post]
25 Nov 2008, 5:01 am
By Jason Derry -- King Pharmaceuticals, Inc. has announced that it will purchase Alpharma Inc. for about $1.6 billion in cash. [read post]
19 Nov 2008, 5:52 am
By Kwame Mensah -- Last month, King Pharmaceuticals, Inc. announced that it is extending its previously announced tender offer for all outstanding shares of Class A Common Stock of Alpharma Inc. [read post]
19 Sep 2008, 6:00 pm
: (Spicy IP), India: Supreme Court on exclusive marketing rights: (Spicy IP), Japan: First induced pluripotent stem (iPS) cell patent at Kyoto University: (Competitive Info), Slovenia: Supplementary protection certificates in Slovenia: (The SPC Blog), United States: Biotech/pharma lobbying scoreboard – second quarter update – part II: (Patent Docs), United States: Ferring Pharmaceuticals argues to bring down direct purchaser suits: (Law 360), United States: Transferred… [read post]
16 Jul 2008, 1:00 pm
King Bio Pharmaceuticals, Inc. (2003) 107 Cal.App.4th 1336, 1346; see, e.g., Sargent Fletcher, Inc. v. [read post]
